Quick Answer
ENvue Medical, Inc. reported Cash and Equivalents of $7.74 million for fiscal year 2021.
ENvue Medical, Inc. Cash and Equivalents — Annual History
| Fiscal Year | Cash and Equivalents | YoY Change |
|---|---|---|
| 2021 | $7.74M | +8.3% |
| 2020 | $7.14M | +433.8% |
| 2019 | $1.34M | +49.3% |
| 2018 | $896.0K | -79.4% |
| 2017 | $4.36M | +4013.2% |
| 2016 | $106.0K | -93.4% |
| 2015 | $1.61M | +1693.3% |
| 2014 | $90.0K | -4.3% |
| 2013 | $94.0K | — |
Quarterly Cash and Equivalents
| Quarter Ending | Cash and Equivalents | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $6.95M | +432.6% | +72.5% |
| June 30, 2025 | $4.03M | — | +435.9% |
| December 31, 2024 | $752.0K | — | -42.4% |
| September 30, 2024 | $1.30M | — | -78.2% |
| March 31, 2022 | $5.99M | -24.7% | -22.6% |
| December 31, 2021 | $7.74M | +8.3% | -10.0% |
| September 30, 2021 | $8.60M | +170.3% | +51.6% |
| June 30, 2021 | $5.67M | — | -28.7% |
- ENvue Medical, Inc. showed an increase of +8.3% in Cash and Equivalents compared to the prior fiscal year.
- Over the 2013–2021 period, ENvue Medical, Inc.’s cash and equivalents has grown by 8130.9% (from $94.0 thousand to $7.74 million).
- The most recent figure is from ENvue Medical, Inc.’s fiscal year 2021 report (Form 10-K), filed with the SEC on April 15, 2022.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: